Best known in construction circles as one of the longest operating providers of scaffolding and scaffolding services, Acrow Formwork and Construction Services (ASX: ACF) is set to embark into the lucrative world of Jump Forms where they have hit the ground running with two immediate contract wins. While scaffolding has long been the most reliable
Read More
Telecommunications infrastructure company Megaport (ASX MP1), has announced their full-year results today along with updating the market on their struggles with inflation. To deal with these macroeconomic issues, Megaport management recently made the decision to lay off a total 35 positions across its business. To remove liability, the Company paid out a total of $1.6
Read More
Medical device company Medical Developments International (ASX:MVP) has successfully raised $20 million from institutional investors as part of their plans to raise a total of $30 million to fund global expansion plans for its flagship non-opioid painkiller, Penthrox (aka the Green Whistle). Capital raised at the Offer Price of $2.00 per share will be used to
Read More
Although corporate turmoil has plagued Booktopia (ASX: BKG) over the past 12 months, with 90% of the company valuation slashed, there may soon be some light at the end of the tunnel with the books retailer set to start fresh at a new distribution facility. The move, which will only be down the road from
Read More
With today’s insane cost of living, if there’s a cheaper option to something you best believe I’m picking it. I am all about home brand cheese and ibuprofen sans shiny box. Pharmaceutical company Acrux (ASX: ACR) gets it, having lodged an application with the US Food and Drug Administration (FDA) for review of their generic
Read More
Aptar Pharma has deemed now the perfect time to exercise their option to purchase an inventive piece of Pharmaxis’ (ASX: PXS) technology. In August, 2021 Aptar signed an exclusive option agreement to Pharmaxis’ “Orbital” technology, handing over USD $250,000. Now, a little under a year later, Aptar is deploying USD $2.5 million to exercise the
Read More
Four months since appointing receivers to untangle the mess of a business created by Buddy Technologies (ASX: BUD), receivers have found one asset of value to sell off but that won’t come even remotely close to paying off debts owed by the tech company which has been suspended by the ASX since April 2022 following
Read More
Medical equipment manufacturing company Allegra Orthopaedics (ASX: AMT) reveals further evidence of safety of its bone regeneration device after completing a large animal study. The animal study was undertaken at SAHMRI-PIRL (South Australian Health and Medical Research Institute – Preclinical, Imaging and Research Laboratories) under good laboratory practice (GLP) conditions. The research has now progressed
Read More
I recently bought a gorgeous coat from an American website. This thing has travelled the world, having been made in Italy before making its way to some warehouse in the States and finally, to protect me from the Melbourne cold. When you think about it, the air miles on this thing are insane. Aside from
Read More
Although there is a global shortage in their products, semiconductor tech company Revasum (ASX: RVS) continues to be plagued by cash flow problems despite delivering a 60% increase in revenue with their struggles being attributed to supply chain problems. The Company revealed a revenue uptick from USD $7.4 million for the half year ended 30
Read More
